Version 1
: Received: 4 February 2023 / Approved: 7 February 2023 / Online: 7 February 2023 (02:04:31 CET)
Version 2
: Received: 14 February 2023 / Approved: 15 February 2023 / Online: 15 February 2023 (02:47:13 CET)
De Lazzari, B.; Capoccia, M.; Badagliacca, R.; Bozkurt, S.; De Lazzari, C. IABP Versus Impella Support in Cardiogenic Shock: “In Silico” Study. J. Cardiovasc. Dev. Dis.2023, 10, 140.
De Lazzari, B.; Capoccia, M.; Badagliacca, R.; Bozkurt, S.; De Lazzari, C. IABP Versus Impella Support in Cardiogenic Shock: “In Silico” Study. J. Cardiovasc. Dev. Dis. 2023, 10, 140.
De Lazzari, B.; Capoccia, M.; Badagliacca, R.; Bozkurt, S.; De Lazzari, C. IABP Versus Impella Support in Cardiogenic Shock: “In Silico” Study. J. Cardiovasc. Dev. Dis.2023, 10, 140.
De Lazzari, B.; Capoccia, M.; Badagliacca, R.; Bozkurt, S.; De Lazzari, C. IABP Versus Impella Support in Cardiogenic Shock: “In Silico” Study. J. Cardiovasc. Dev. Dis. 2023, 10, 140.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.